Morgan Stanley Discount Zert NXPI.../ DE000ME8MZ41 /
23/05/2024 18:54:49 | Var.-0.47 | Denaro22:00:33 | Lettera22:00:33 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
226.18EUR | -0.21% | - Quantità in denaro: - |
- Quantità in lettera: - |
NXP Semiconductors N... | - USD | 27/09/2024 | Call |
GlobeNewswire
00:37
AXTI Stockholders: Robbins LLP Reminds AXTI Stockholders of Securities Fraud Class Action Against AX...
GlobeNewswire
00:27
Mediacom Communications Ready to Connect Customers in First Phase of 221-Mile Seminole County Fiber ...
GlobeNewswire
00:25
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with Sub...
GlobeNewswire
00:07
ROSEN, A TOP RANKED LAW FIRM, Encourages Autodesk, Inc. Investors to Secure Counsel Before Important...
GlobeNewswire
00:02
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel ...
GlobeNewswire
00:01
The Dominican Republic and Purdue University Sign MOU to Drive Semiconductor Growth
GlobeNewswire
00:00
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® A...
GlobeNewswire
23/05
ROSEN, A TOP RANKED LAW FIRM, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Im...
GlobeNewswire
23/05
Coherus Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-chemokine recept...
GlobeNewswire
23/05
Parks! America, Inc. Announces Glass Lewis Recommends Parks! America Shareholders Vote “FOR” Each of...
GlobeNewswire
23/05
CORRECTION – The Herzfeld Caribbean Basin Fund, Inc. Announces Distribution in Stock and Cash
GlobeNewswire
23/05
Mountain America Credit Union Named Utah's Leading SBA Lender for Third Consecutive Year
GlobeNewswire
23/05
Stockholder Alert: Robbins LLP Informs Investors that a Class Action has been filed Against Cambium ...
GlobeNewswire
23/05
3Daughters to Participate in Women’s Health Panel During the 2024 BIO International Convention in Sa...
GlobeNewswire
23/05
Elicio Therapeutics Announces Preliminary Data from the Ongoing AMPLIFY-7P Phase 1a Study of ELI-002...